$0.08
0.00 (0%)
Neose Technologies, Inc. (NTEC)
CAPS Rating:
A clinical stage biopharmaceutical company focused on the development of next-generation therapeutic proteins.
A clinical stage biopharmaceutical company focused on the development of next-generation therapeutic proteins.